Bristol Myers Squibb says Alzheimer’s is the biggest market for new schizophrenia drug
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023. Adam ...
Tag: Alzheimers
FDA approves new Alzheimer’s treatment, donanemab from Eli Lilly
The Food and Drug Administration approved a new Alzheimer's treatment called donanemab on Tuesday, clearing the way for the third ...
Biogen tops profit estimates as cost cuts take hold, Alzheimer’s drug Leqembi launch picks up
A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021.Dado Ruvic ...
Biogen scraps controversial Alzheimer’s drug Aduhelm
Biogen is pulling the plug on the controversial drug Aduhelm, the first drug cleared by government health officials for treating ...
Is it genetic? What experts say about the risk of diabetes, Alzheimer’s, ADHD and more
"Do you have a family history of that?" It's a question that often comes up in health settings, but how much ...
FDA gives full approval to a drug designed to slow Alzheimer’s disease
FDA gives full approval to a drug designed to slow Alzheimer's disease - CBS News
Eli Lilly expects FDA decision on Alzheimer’s treatment donanemab by the end of the year
Eli Lilly on Monday said it applied for full U.S. Food and Drug Administration approval of its Alzheimer's treatment, donanemab, ...
